| For: | Tanaka N, Kimura T, Fujimori N, Ichise Y, Sano K, Horiuchi A. Non-alcoholic fatty liver disease later diagnosed as myotonic dystrophy. World J Hepatol 2020; 12(9): 685-692 [PMID: 33033573 DOI: 10.4254/wjh.v12.i9.685] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i9/685.htm |
| Number | Citing Articles |
| 1 |
Nicole M. Ralbovsky, Paromita Dey, Andrew Galfano, Bijan K. Dey, Igor K. Lednev. A Novel Method for Detecting Duchenne Muscular Dystrophy in Blood Serum of mdx Mice. Genes 2022; 13(8): 1342 doi: 10.3390/genes13081342
|
| 2 |
Jenna Damon, Colby Chase, Tomoyasu Higashimoto. Primary amenorrhea in myotonic dystrophy type 1: Initial presentation versus incidental finding on whole genome sequencing. American Journal of Medical Genetics Part A 2024; 194(9) doi: 10.1002/ajmg.a.63650
|
| 3 |
Fabio Giannone, Lorenzo Cinelli, Arielle Bellissard, Zineb Cherkaoui, Emanuele Felli, Antonio Saviano, Pierre Mayer, Patrick Pessaux. Spontaneous idiopathic liver hemorrhage: a systematic review of a rare entity. European Journal of Trauma and Emergency Surgery 2024; 50(6): 2765 doi: 10.1007/s00068-024-02500-3
|
| 4 |
Zachary Dewald, Oluwafolajimi Adesanya, Haneui Bae, Andrew Gupta, Jessica M. Derham, Ullas V. Chembazhi, Auinash Kalsotra. Altered drug metabolism and increased susceptibility to fatty liver disease in a mouse model of myotonic dystrophy. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-53378-z
|
| 5 |
Adam Morton. Epigastric pain and partial ptosis. Diabetic Medicine 2023; 40(5) doi: 10.1111/dme.15018
|
| 6 |
Saskia Scholten, Janel A.M. Peterson, Lynn B. Orriëns, Luca Pastorelli, Giovanni Meola, Benedikt Schoser, Hilde M.H. Braakman. 288th ENMC International Workshop. Towards better diagnosing, understanding and treating gastrointestinal symptoms in myotonic dystrophy: extended insights and practical recommendations. 16-18 May 2025, Hoofddorp, the Netherlands. Neuromuscular Disorders 2025; : 106250 doi: 10.1016/j.nmd.2025.106250
|
| 7 |
Stephen J Winters. Endocrine Dysfunction in Patients With Myotonic Dystrophy. The Journal of Clinical Endocrinology & Metabolism 2021; 106(10): 2819 doi: 10.1210/clinem/dgab430
|
| 8 |
Aono Fukumoto, Tomoki Yamanaka, Motoaki Yanaizu, Masayuki Nakamori, Manami Hama, Yoshiaki Yasumizu, Kana Shiotsu, Tsuyoshi Matsumura, Curtis A Nutter, Tomoya Kubota, Harutoshi Fujimura, Yoshihiro Kino, Maurice S Swanson, Kimiko Inoue, Masanori P Takahashi. Transcriptome alterations underlying metabolic dysfunction and liver disease in myotonic dystrophy type 1. Human Molecular Genetics 2025; 34(20): 1718 doi: 10.1093/hmg/ddaf124
|
